principia

Principia Biopharma announces $100M IPO

Principia Biopharma announces $100M IPO

Principia is a spinoff from Jack Taunton’s lab at UCSF.

Principia Biopharma files for an $86 million IPO

Principia Biopharma files for an $86 million IPO

Principia plans to list on the Nasdaq under the symbol PRNB.

AbbVie and Principia Announce Collaboration on Oral Immunoproteasome Inhibitors

AbbVie and Principia Announce Collaboration on Oral Immunoproteasome Inhibitors

The collaboration is aimed at developing first-in-class oral therapies that bring the power of proteasome inhibition safely into the field of immunology.